Amneal Announces New Biosciences Unit With Charles Lucarelli As President

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Amneal today announced the creation of Amneal Biosciences, a wholly-owned subsidiary of Amneal Pharmaceuticals LLC ( Amneal Biosciences will focus exclusively on the commercialization of high-barrier-to-entry generic and specialty pharmaceuticals such as injectables, oncologics and biosimilars to healthcare providers globally.